Asthma Medication Receives New Warning
Links to Fileshttps://ezproxy.stevenson.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=rzh&AN=107811912&site=eds-live&scope=site
MetadataShow full item record
Type of Work2 pages
DepartmentSandra R. Berman School of Nursing and Health Professions
Citation of Original PublicationAschenbrenner, D. S. (2015). Asthma medication receives new warning. AJN American Journal Of Nursing, 115(1), 22-23. doi:10.1097/01.NAJ.0000459621.92420.e0
The labeling of omalizumab (Xolair), a drug used to treat allergic asthma, now carries a warning that its use may slightly increase the risk of cardiovascular complications. The drug may also pose an increased risk of inducing cancer.